Progesterone and cerebral ischaemia: The relevance of ageing

Journal of Neuroendocrinology

Volumn 25, Issue 11, 2013, Pages 1088-1094

  Wong, R ^a   Bath, P M W ^a   Kendall, D ^a   Gibson, C L ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Ischaemia; Neuroactive steroids; Neuroprotection; Progestogens; Steroids; Stroke

Indexed keywords

PROGESTERONE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NEUROPROTECTIVE AGENT;

AGING; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMAN; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TREATMENT OUTCOME; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; STROKE;

AGING; ANIMALS; BRAIN ISCHEMIA; HUMANS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; PROGESTERONE; STROKE;

EID: 84886643243     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12042     Document Type: Review

References (80)

1. WHO. The World Health Report (2003). 2003; Available at: http://www.who.int/whr/2003/en/whr03_en.pdf.
2. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988; 19: 1083-1092.
3. Elijovich L, Chong JY. Current and future use of intravenous thrombolysis for acute ischaemic stroke. Curr Atheroscler Rep 2010; 12: 316-321.
4. Green AR. Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective. Clin Exp Pharmacol Physiol 2002; 29: 1030-1034.
5. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 2004; 19: 151-167.
6. Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinshnitz C. Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Int J Stroke 2012; 7: 407-418.
7. Hossmann K-A. Pathophysiological basis of translational stroke research. Folio Neuropathol 2009; 47: 213-227.
8. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol 2000; 57: 418-420.
9. Rojas JI, Zurru MC, Romano M, Patrucco L, Cristiano E. Acute ischaemic stroke and transient ischaemic attack in the very old - risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol 2007; 14: 895-899.
10. Moulin T, Tatu L, Vuiller F, Berger E, Chavot D, Rumbach L. Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcomes of 1776 consecutive patients from the Besancon stroke registry. Cerebrovasc Dis 2000; 10: 261-271.
11. Allen CL, Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke 2008; 3: 105-116.
12. Hankey GJ. Smoking and risk of stroke. J Cardiovasc Risk 1999; 6: 207-211.
13. Kirshner HS. Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J Neurol Sci 2009; 279: 1-8.
14. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40: 1082-1090.
15. Liu F, Yuan R, Benashski SE, McCullough LD. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009; 29: 792-802.
16. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke 1998; 29: 159-165.
17. Kharlamov A, Kharlamov E, Armstrong DM. Age-dependent increase in infarct volume following photochemically induced cerebral infarction: putative role of astroglia. J Gerontol A Biol Sci Med Sci 2000; 55: B135-B141.
18. Sutherland GR, Dix GA, Auer RN. Effect of age in rodent models of focal forebrain ischaemia. Stroke 1996; 27: 1663-1667.
19. Chen Y, Sun FY. Age-related decrease of striatal neurogenesis is associated with apoptosis of neural precursors and newborn neurons in rat brain after ischaemia. Brain Res 2007; 1166: 9-19.
20. Li N, Kong X, Ye R, Yang Q, Han J, Xiong L. Age-related differences in experimental stroke: possible involvement of mitochondrial dysfunction and oxidative damage. Rejuvenation Res 2011; 14: 261-273.
21. Shapira S, Sapir M, Wengier A, Grauer E, Kadar T. Aging has a complex effect on a rat model of ischaemic stroke. Brain Res 2002; 925: 148-158.
22. Sieber MW, Claus RA, Witte OW, Frahm C. Attenuated inflammatory response in aged mice brains following stroke. PLoS One 2011; 6: e26288.
23. Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P, Hernangomez M, Montagne A, Liot G, Guazza C. Tissue plasminogen activator prevents white matter damage following stroke. J Exp Med 2011; 208: 1229-1242.
24. Liu F, Akella P, Benashski SE, Xu Y, McCullough LD. Expression of NA-K-Cl transporter and edema formation are age dependent after ischaemic stroke. Exp Neurol 2010; 224: 356-361.
25. Liu F, Benashski SE, Persky R, Xu Y, Li J, McCullough LD. Age-related changes in AMP-activated protein kinase after stroke. Age (Dordr) 2012; 34: 157-168.
26. Won SJ, Xie L, Kim SH, Tang H, Wang Y, Mao X, Banwait S, Jin K. Influence of age on the response to fibroblast growth factor-2 treatment in a rat model of stroke. Brain Res 2006; 1123: 237-244.
27. Wang RY, Wang PS, Yang YR. Effect of age in rats following middle cerebral artery occlusion. Gerontology 2003; 49: 27-32.
28. Wang RY, Yu SM, Yang YR. Treadmill training effects in different age groups following middle cerebral artery occlusion in rats. Gerontology 2005; 51: 161-165.
29. Atella MJ, Nattinville A, Stein DG. Hormonal state affects recovery from fontal cortex lesions in adult female rats. Behav Neur Biol 1987; 48: 352-367.
30. Roof RL, Duvdevani R, Stein DG. Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res 1993; 607: 333-336.
31. Stein DG. Is progesterone a worthy candidate as a novel therapy for traumatic brain injury? Dialogues Clin Neurosci 2011; 13: 352-359.
32. Wright DW, Kellerman AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007; 49: 391-402.
33. Xiao G, Wei J, Yan W, Wand W, Lu Z. Improved outcomes from the administration of progesterone to patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008; 12: R61.
34. Aggarwal R, Medhi B, Pathak A, Dhawan V, Chakrabarti A. Neuroprotective effect of progesterone on acute phase changes induced by partial global cerebral ischaemia in mice. J Pharm Pharmacol 2008; 60: 731-737.
35. Alkayed NJ, Traystman RJ, Hurn PD, Miller VM. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 2000; 31: 161-168.
36. Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L. Two different molecular mechanisms underlying progesterone neuroprotection against ischaemic brain damage. Neuropharmacology 2008; 55: 127-138.
37. Chen J, Chopp M, Li Y. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci 1999; 171: 24-30.
38. Dang J, Mitkari B, Kipp M, Beyer C. Gonadal steroids prevent cell damage and stimulate behavioural recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun 2011; 25: 715-726.
39. Gibson CL, Murphy SP. Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J Cereb Blood Flow Metab 2004; 24: 805-813.
40. Gibson CL, Constantin DC, Prior MJW, Bath PMW, Murphy SP. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischaemia. Exp Neurol 2005; 193: 522-530.
41. Gibson CL, Coomber B, Murphy SP. Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 2011; 134: 2125-2133.
42. Gonzalez-Vidal MD, Cervera-Gaviria M, Ruelas R, Escobar A, Morali G, Cervantes M. Progeserone: protective effects on the cat hippocampal neuronal damage due to acute global cerebral ischaemia. Arch Med Res 1998; 29: 117-124.
43. Ishrat T, Sayeed I, Atif F, Stein DG. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischaemia in rats. Brain Res 2009; 1257: 94-101.
44. Ishrat T, Sayeed I, Atif F, Hua F, Stein DG. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischaemia by regulating the expression of matrix metalloproteinases. Exp Neurol 2010; 226: 183-90.
45. Ishrat T, Sayeed I, Atif F, Hua F, Stein DG. Progesterone is neuroprotective against ischaemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 2012; 210: 442-450.
46. Jiang N, Chopp M, Stein D, Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 1996; 735: 101-107.
47. Jiang C, Wang J, Li X, Liu C, Chen N, Hao Y. Progesterone exerts neuroprotective effects by inhibiting inflammatory response after stroke. Inflamm Res 2009; 58: 619-624.
48. Kumon Y, Kim SC, Tompkins P, Stevens A, Sakaki S, Loftus CM. Neuroprotective effect of postischaemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischaemia. J Neurosurg 2000; 92: 848-852.
49. Morali G, Letechipia-Vallejo G, Lopez-Loeza E, Montes P, Hernandez-Morales L, Cervantes M. Post-ischaemic administration of progesterone in rats exerts neuroprotective effects in the hippocampus. Neurosci Lett 2005; 382: 286-290.
50. Murphy SJ, Littleton-Kearney MT, Hurn PD. Progesterone administration during reperfusion, but not preischaemia alone, reduces injury in ovariectomised rats. J Cereb Blood Flow Metab 2002; 22: 367-388.
51. Sayeed I, Guo Q, Hoffman SW, Stein DG. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med 2006; 47: 381-389.
52. Sayeed I, Wali B, Stain DG. Progesterone inhibits ischaemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 2007; 25: 151-159.
53. Wang J, Jiang C, Liu C, Li X, Chen N, Hao Y. Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res 2010; 209: 119-22.
54. Choi YC, Lee JH, Hong KW, Lee KS. 17 b-Estradiol prevents focal cerebral ischaemic damage via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam Clin Pharmacol 2004; 18: 547-557.
55. Coomber B, Gibson CL. Sustained levels of progesterone prior to the onset of cerebral ischaemia are not beneficial to female mice. Brain Res 2010; 1361: 124-32.
56. Toung TJ, Chen T-Y, Littleton Kearney MT, Hurn PD, Murphy SJ. Effects of combined estrogen and progesterone in brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab 2004; 24: 1160-1166.
57. Murphy SJ, Traystman RJ, Hurn PD. Progesterone exacerbates striatal stroke injury in progesterone-deficient animals. Stroke 2000; 31: 367-388.
58. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Makuch R, Horwitz RJ. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001; 345: 1243-1249.
59. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-611.
60. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ. Effect of estrogen plus progestin on stroke in post-menopausal women-the Women's Health Initiative: a randomized trial. JAMA 2003; 289: 2673-2674.
61. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 2004; 304: 1269-1273.
62. Gibson CL, Gray LJ, Bath PMW, Murphy SP. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008; 131: 318-328.
63. Wali B, Sayeed I, Stein DG. Improved behavioural outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci 2011; 29: 61-71.
64. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) stroke. Neurology 1998; 50: 864-870.
65. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ. Progesterone receptors: form and function in the brain. Front Neuroendocrinol 2008; 29: 313-339.
66. He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004; 189: 404-412.
67. Brann DW, Zamorano PL, De Sevilla L, Mahesh VB. Expression of glutamate receptor subunits in the hypothalamus of the female rat during the afternoon of the proestrous luteinizing hormone surge and effects of antiprogestin treatment and aging. Neuroendocrinology 2005; 81: 120-128.
68. Coughlan T, Gibson CL, Murphy SP. Modulatory effects of progesterone on NOS-2 expression in vivo and in vitro. J Neurochem 2005; 93: 932-942.
69. Gebel JM, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral haemorrhage. Stroke 2002; 33: 2636-2641.
70. Duvdevani R, Roof RL, Fulop Z, Hoffman SW, Stein DG. Blood-brain barrier breakdown and edema formation following frontal cortical contusion: does hormonal status play a role? J Neurotrauma 1995; 12: 65-75.
71. Guo Q, Sayeed I, Baronne L, Hoffman SW, Guennoun R, Stain DG. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol 2006; 198: 469-478.
72. Roof RL, Duvdevani R, Heyburn JW, Stein DG. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol 1996; 138: 246-251.
73. Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008; 149: 3167-3175.
74. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002; 143: 205-212.
75. Djebali MS, Hoffman SW, Stein DG. Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience 2004; 123: 349-359.
76. Anyanwu EC. Neurochemical changes in the aging process: implications in medication in the elderly. Sci World J 2007; 7: 1603-1610.
77. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab 2008; 7: 476-484.
78. Dirnagl U, Simon RP, Hallenbeck JM. Ischaemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248-254.
79. Mantha AK, Moorthy K, Cowsik SM, Baquer NZ. Membrane associated functions of neurokinin B (NKB) on Abeta (25-35) induced toxicity in aging rat brain synaptosomes. Biogerontology 2006; 7: 19-33.
80. Atif F, Yousuf S, Sayeed I, Ishrat T, Hua F, Stein DG. Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischaemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection. Neuropharmacology 2013; 67: 78-87.